Multilocus genotypes spanning estrogen metabolism associated with breast cancer and fibroadenoma

Rejuvenation Research

Volumn 9, Issue 1, 2006, Pages 56-60

  Corder, Elizabeth H ^a   Hefler, Lukas A ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 17; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; STEROID 5ALPHA REDUCTASE; VITAMIN D RECEPTOR;

ADULT; AGED; ALLELE; BREAST CANCER; CANCER RISK; CELL CYCLE G0 PHASE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ESTROGEN METABOLISM; FEMALE; FIBROADENOMA; GENE LOCUS; GENETIC RISK; GENOTYPE; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; CYTOCHROME P-450 ENZYME SYSTEM; ESTROGENS; FEMALE; FIBROADENOMA; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33646068714     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2006.9.56     Document Type: Conference Paper

References (20)

1. Service RF. New role for estrogen in cancer? Science 1998;279:1631-1633.
2. London SJ, Connolly JL, Schnitt SJ, et al. A prospective study of benign disease and the risk of breast cancer. JAMA 1992;267:941-944.
3. Hutchinson WB, Thomas DB, Hamlin WB, et al. Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst 1980;65:13-20.
4. Hefler LA, Tempfer CB, Grimm C, et al. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer 2004;101:264-269.
5. Huber M, Mundlein A, Dornstauder E, et al. Accessing single nucleotide polymorphisms in genomic DNA by direct multiplex polymerase chain reaction amplification on oligonucleotide microassays. Anal Biochem 2002;303:25-33.
6. Huang C-S, Chern H-D, Chang K-J, et al. Breast cancer risk associated with genotype polymorphism of the estrogen metabolizing genes CYP19, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 1999;59:4870-4875.
7. Thompson PA, Shields PG, Freudenheim JL, et al. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 1998;58:2107-2110.
8. Hanna IH, Dawling S, Roodi N, et al. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 2000;60:3440-3444.
9. Ambrosone CB, Freudenheim Jl, Graham S, et al. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 1995;55:3483-3485.
10. Taioli E, Trachman J, Chen X, et al. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 1995;55:3757-3758.
11. Bergman-Jungestrom M, Wingren S. Catechol-O-methyl-transferase (COMT) gene polymorphism and breast cancer risk in young women. Br J Cancer 2001;85:859-862.
12. Woodbury MA, Clive J. Clinical pure types as a fuzzy partition. J Cybernet 1974;4:111-121.
13. Woodbury MA, Clive J, Garson A. Mathematical typology: a grade of membership technique for obtaining disease definition. Comput Biomed Res 1978;11:277-298.
14. Woodbury MA, Manton KG, Tolley DH. A general model for statistical analysis using fuzzy sets: sufficient conditions for identifiability and statistical properties. Informat Sci 1994;1:149-180.
15. Corder EH, Woodbury MA, Volkmann I, et al. Density profiles of Alzheimer disease regional brain pathology for the Huddinge Brain Bank: pattern recognition emulates and expands upon Braak staging. Exp Gerontol 2000;35:851-864.
16. Corder EH, Woodbury MA, Manton KG, et al. Grade-of-membership sibpair linkage analysis maps the IDDM11 locus to chromosome 14q24.3-q31: a pattern recognition approach to linkage. Ann Hum Genet 2001;65:387-394.
17. Iivonen S, Corder E, Lehtovirta M, et al. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer's disease. Neurology 2004;62:1170-1176.
18. Helisalmi S, Hiltunen M, Vepsäläinen S, et al. Genetic variation in apolipoprotein D and Alzheimer's disease. J Neurol 2004;251:951-957.
19. Hallmayer JF, Kalaydjieva L, Badcock J, et al. Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. Am J Hum Genet 2005;77:468-476.
20. Corder EH, Ervin JF, Lockhart E, et al. Cardiovascular damage in Alzheimer disease: autopsy findings from the Bryan ADRC. J Biomed Biotechnol 2005;2005:189-197.